Which to Treat First When Someone Has a Sellar Region Tumor and a Brain Aneurysm
Official title: China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on .
The short version
This study asks which of two problems in the head should be treated first.
Read our full plain-language summary
What the trial team says
The goal of this observational study is to learn about the treatment strategies for tumor in sellar region with unruptured intracranial aneurysms in the Chinese population. The main question it aims to answer is: For patients with tumor in sellar region combined with unruptured intracranial aneurysms, which condition should be treated first?
Key facts
- Registry number
- NCT07809178
- Conditions studied
- Unruptured Intracranial Aneurysms, Pituitary Neuroendocrine Tumor, Craniopharyngioma, Meningioma, Germinoma, Rathke Cleft Cysts, Chordoma, Optic Pathway Glioma, Hypothalamic Neoplasms
Where it is running
This trial lists 1 site.
-
China
- Beijing Tiantan Hospital affiliated to Capital Medical University (Beijing)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.